|
|
||||||||
Ann Thorac Surg 1994;58:1240-1246
© 1994 The Society of Thoracic Surgeons
Division of Vascular Surgery, Oregon Health Sciences University, Portland, Oregon, USA
* Address reprint requests to Dr Porter, Division of Vascular Surgery, OP-11, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd, Portland, OR 97201-3098.
Atherosclerosis is a leading cause of death and disability in the Western world, and an important risk factor for it may be an elevated level of the plasma amino acid homocysteine. The biochemical characteristics of homocysteine, along with historical, laboratory, and clinical evidence for its pathologic role in atherosclerosis, are reviewed. Possible therapies for reducing elevated homocysteine levels and the possible impact of therapy in atherosclerosis are examined.
This article has been cited by other articles:
![]() |
D. W. Jacobsen Homocysteine and vitamins in cardiovascular disease Clin. Chem., August 1, 1998; 44(8): 1833 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sutton-Tyrrell, A. Bostom, J. Selhub, and C. Zeigler-Johnson High Homocysteine Levels Are Independently Related to Isolated Systolic Hypertension in Older Adults Circulation, September 16, 1997; 96(6): 1745 - 1749. [Abstract] [Full Text] |
||||
![]() |
Y. N. Li, S. Gulati, P. J. Baker, L. C. Brody, R. Banerjee, and W. D. Kruger Cloning, Mapping and RNA Analysis of the Human Methionine Synthase Gene Hum. Mol. Genet., December 1, 1996; 5(12): 1851 - 1858. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |